EnzyFluo™ ERK Phosphorylation Assay Kit

ICE

For quantitative fluorescent immunoenzymatic assay of ERK1/2 phosphorylation status in cultured cells. Key Features: New and improved. Total assay time reduced from the standard 21 hours to 6.5 hours (hands-on time 2.5 hrs). Simple and convenient. Cells are directly cultured in 96-well plates. No cell lysis necessary. Accurate and high-throughput. Protein phosphorylation is normalized to total cellular protein in the same well, greatly minimizing well-to-well variations. Can be readily automated as a high-throughput 96-well plate assay for thousands of samples per day. Method: Cell-based ELISA (FL360/450nm, 530/585nm). Samples: Cells. Species: Human, mouse, rat. Procedure: Assay takes Assay takes 6.5 hrs, hands-on time 2.5 hrs. Kit size: 100 tests.

Application: For quantitative fluorescent immunoenzymatic assay of ERK1/2 phosphorylation status in cultured cells.
Key Features: Safe. Non-radioactive assay.
Simple and convenient. Total and pERK can be measured in the same sample.
Method: FL360/450nm, 530/585nm
Samples: Cells
Species: Human, mouse, rat.
Size: 100 tests
Shelf Life: 6 months
More Details: The mitogen-activated protein kinase (MAPK/ERK) pathway plays a key role in cell proliferation, differentiation and migration. Stimulation by mitogens eventually leads to phosphorylation of ERK1 (T202/Y204) and ERK2 (T185/Y187). The MAPK/ERK cascade presents many interesting drug targets for the development of cancer therapies. BioAssay Systems cell-based ELISA measures dually phosphorylated ERK1/2 in whole cells and normalizes the signal to the total protein content. This simple and efficient assay eliminates the need for cell lysate preparation and can be used to study kinase signaling and the effects of kinase inhibitors on cells. In this assay, cells are grown in 96-well plates and treated with ligands or drugs. Cells are then fixed and permeabilized in the wells. ERK1/2 phosphorylation (pERK) using a fluorescent ELISA followed by total protein measurement in each well.